Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/22/2020 10/23/2020 10/26/2020 10/27/2020 10/28/2020 Date
233.98(c) 232.66(c) 234.91(c) 239.78(c) 232.1(c) Last
2 743 224 2 268 967 2 384 169 3 268 887 2 828 448 Volume
+3.28% -0.56% +0.97% +2.07% -3.20% Change
More quotes
Financials (USD)
Sales 2020 21 955 M - -
Net income 2020 3 507 M - -
Net Debt 2020 15 370 M - -
P/E ratio 2020 51,3x
Yield 2020 0,30%
Sales 2021 25 009 M - -
Net income 2021 4 168 M - -
Net Debt 2021 12 078 M - -
P/E ratio 2021 44,6x
Yield 2021 0,33%
Capitalization 170 B 170 B -
EV / Sales 2020 8,46x
EV / Sales 2021 7,29x
Nbr of Employees 60 000
Free-Float 74,1%
More Financials
Company
Danaher Corporation is an industrial and technologic group organized around three families of products: - medical equipment (75.4% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (13.8%): systems of quality control of waters, disinfection, etc.; - identification products (10.8%). Net sales are distributed... 
More about the company
Notations Surperformance© of Danaher Corporation
Trading Rating : Investor Rating :
More Ratings
All news about DANAHER CORPORATION
10/27DANAHER : Cytiva strengthens support to diagnostics industry with new labs, serv..
AQ
10/23DANAHER : Reports Third Quarter 2020 Results
AQ
10/22DANAHER : 3Q Profit, Sales Rise
DJ
10/22DANAHER : 3Q Earnings Snapshot
AQ
10/22DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
10/22DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
10/22DANAHER : Reports Third Quarter 2020 Results
PR
10/22DANAHER CORPORATION : 3rd quarter results
CO
10/22DANAHER CORPORATION : Press Release
CO
10/19DANAHER CORPORATION : quaterly earnings release
10/15DANAHER : Beckman Coulter receives BARDA funding to validate Monocyte Distributi..
PR
10/13DANAHER : Cytiva in U.S. Agreement to Expand Capacity for Covid-19 Vaccine-Relat..
DJ
10/13U.S. govt signs deal to make more COVID-19 vaccine components
RE
10/09DANAHER : Unit's SARS-CoV-2 IgM Antibody Test Gets FDA Emergency Use OK
DJ
10/09DANAHER : Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Us..
PR
More news
News in other languages on DANAHER CORPORATION
10/22EN DIRECT DES MARCHES : Atos, Eurofins, Hermès, Pernod Ricard, STMicro, Thales, ..
10/22La peur du reconfinement
10/19DANAHER CORPORATION : Veröffentlichung des Quartalsergebnisses
10/19DANAHER CORPORATION : publication des résultats trimestriels
07/23L'agenda des publications d'entreprises explose
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 249,95 $
Last Close Price 239,78 $
Spread / Highest target 14,7%
Spread / Average Target 4,24%
Spread / Lowest Target -42,4%
EPS Revisions
Managers
NameTitle
Rainer M. Blair President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Walter G. Lohr Independent Director
Sector and Competitors